Prevalence of venous thromboembolism in critically ill patients with COVID-19.
作者信息
Hippensteel Joseph A, Burnham Ellen L, Jolley Sarah E
机构信息
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
出版信息
Br J Haematol. 2020 Aug;190(3):e134-e137. doi: 10.1111/bjh.16908. Epub 2020 Jun 24.
Abstract
摘要
相似文献
1
Prevalence of venous thromboembolism in critically ill patients with COVID-19.新型冠状病毒肺炎危重症患者静脉血栓栓塞症的患病率
Br J Haematol. 2020 Aug;190(3):e134-e137. doi: 10.1111/bjh.16908. Epub 2020 Jun 24.
2
Venous thromboembolism in non-critically ill patients with COVID-19 infection.COVID-19 感染非危重症患者的静脉血栓栓塞症。
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
3
Management of venous thromboembolism during the COVID-19 pandemic.2019冠状病毒病大流行期间静脉血栓栓塞的管理
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):897-898. doi: 10.1016/j.jvsv.2020.05.005. Epub 2020 May 23.
4
Severe COVID-19 disease and thromboinflammation.重症新型冠状病毒肺炎与血栓性炎症
Arch Cardiol Mex. 2020;90(3):257-258. doi: 10.24875/ACM.M20000075.
5
COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?新冠病毒感染相关的高黏滞血症：炎症与血栓形成倾向之间的联系？
Lancet. 2020 Jun 6;395(10239):1758-1759. doi: 10.1016/S0140-6736(20)31209-5. Epub 2020 May 25.
6
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.在新型冠状病毒肺炎（COVID-19）的治疗中应注意静脉血栓栓塞的预防。
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
7
Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?新型冠状病毒 2 型患者的静脉血栓栓塞症：仅仅是在通气 ICU 患者中存在问题，还是有更多问题？
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01201-2020. Print 2020 Jul.
8
Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.接受预防性抗凝治疗的新冠肺炎住院患者的静脉血栓栓塞症
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
9
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.静脉血栓栓塞症及其与 COVID-19 的关联：仍存在争议。
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
10
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.新型冠状病毒肺炎相关静脉血栓栓塞症：走向理想的血栓预防、筛查和治疗方法。
Curr Cardiol Rep. 2020 Jun 11;22(7):52. doi: 10.1007/s11886-020-01327-9.
引用本文的文献
1
COVID-19 Increases the Risk of New Myocardial Infarction in Patients with Old Myocardial Infarction: A Retrospective Observational Study.新冠病毒增加陈旧性心肌梗死患者新发心肌梗死风险：一项回顾性观察研究
Clin Med Insights Cardiol. 2024 Dec 18;18:11795468241301133. doi: 10.1177/11795468241301133. eCollection 2024.
2
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.因新冠肺炎住院患者静脉血栓栓塞症的临床特征及预后：系统评价与荟萃分析
Thromb Update. 2021;2:100037. doi: 10.1016/j.tru.2021.100037. Epub 2021 Mar 19.
3
Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients.血栓炎症生物标志物与急诊科患者的新冠病毒感染及入院状态相关。
Thromb Update. 2021 Dec;5:100090. doi: 10.1016/j.tru.2021.100090. Epub 2021 Nov 19.
4
Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels.对COVID-19住院患者且D-二聚体水平升高者进行静脉血栓栓塞的系统检测。
Thromb Update. 2021;2:100029. doi: 10.1016/j.tru.2020.100029. Epub 2021 Mar 19.
5
Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.炎症对新型冠状病毒肺炎血栓形成及预后的影响：ATTACC/ACTIV-4a试验的二次分析
Res Pract Thromb Haemost. 2023 Sep 16;7(7):102203. doi: 10.1016/j.rpth.2023.102203. eCollection 2023 Oct.
6
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression.探索COVID-19报告的静脉血栓栓塞风险的异质性并与其他病毒性肺炎进行比较：一项系统综述和Meta回归分析
Res Pract Thromb Haemost. 2023 Jul 13;7(5):102146. doi: 10.1016/j.rpth.2023.102146. eCollection 2023 Jul.
7
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis.严重急性呼吸综合征冠状病毒2型肺炎患者血浆中活化因子VII-抗凝血酶复合物水平升高表明组织因子表达增加：与新型冠状病毒肺炎血栓形成倾向的潜在联系。
Diagnostics (Basel). 2022 Nov 14;12(11):2792. doi: 10.3390/diagnostics12112792.
8
Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India.COVID-19 患者预防静脉血栓栓塞症的血栓预防方法：全球最新进展及来自印度的临床见解
Clin Pract. 2022 Sep 23;12(5):766-781. doi: 10.3390/clinpract12050080.
9
Outcomes of Patients With Acute Limb Ischemia in Patients With COVID-19: A Systemic Review and Meta-Analysis.2019冠状病毒病患者急性肢体缺血的预后：一项系统评价和荟萃分析
Cureus. 2022 Jul 27;14(7):e27370. doi: 10.7759/cureus.27370. eCollection 2022 Jul.
10
A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH.对预测COVID-19住院患者静脉血栓栓塞的生物标志物的系统评价：来自国际血栓与止血学会（ISTH）预测与诊断变量科学与标准化委员会的交流
Res Pract Thromb Haemost. 2022 Aug 26;6(6):e12786. doi: 10.1002/rth2.12786. eCollection 2022 Aug.
本文引用的文献
1
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
2
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
3
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
4
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.意大利米兰一家学术医院收治的 COVID-19 患者的静脉和动脉血栓栓塞并发症。
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
5
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
6
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
7
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
8
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
9
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment.国际血栓与止血学会（ISTH）关于新型冠状病毒肺炎（COVID-19）凝血功能障碍识别与管理的临时指南：一则评论
J Thromb Haemost. 2020 Aug;18(8):2060-2063. doi: 10.1111/jth.14860. Epub 2020 Jun 14.
10
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
Zotero 插件